Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belldegrun

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Urological Research|January 1, 1992
Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytesP Ditonno, C L Tso, T Sakata, et al.
The Journal of Urology|October 1, 1992
The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1A S Koo, R Chiu, J Soong, et al.
Seminars in Oncology|October 1, 1991
The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinomaR A Figlin, A S Abi-Aad, A Belldegrun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapyT Cangiano, J Liao, J Naitoh, et al.
Seminars in Oncology|October 1, 1991
Renal cell carcinoma: basic biology and current approaches to therapyA Belldegrun, A S Abi-Aad, R A Figlin, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1991
Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injectionA S Abi-Aad, R A Figlin, A Belldegrun, et al.
European Urology|January 1, 1990
Immunotherapy for advanced renal cell cancer: the role of radical nephrectomyA Belldegrun, A S Koo, B Bochner, et al.
Urology|April 11, 2001
New biologicals for prostate cancer prevention: Genes, vaccines, and immune-based interventionsA J Pantuck, A Zisman, D Henderson, et al.
Cancer Journal (Sudbury, Mass.)|April 28, 2001
Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patientsB J Gitlitz, D M Hoffman, N Moldawer, et al.
European Journal of Radiology|May 1, 1986
CT diagnosis of adrenal abnormalities in patients with primary non-adrenal malignanciesS Hussain, A Belldegrun, S E Seltzer, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Urological Research|January 1, 1992
Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytesP Ditonno, C L Tso, T Sakata, et al.
The Journal of Urology|October 1, 1992
The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1A S Koo, R Chiu, J Soong, et al.
Seminars in Oncology|October 1, 1991
The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinomaR A Figlin, A S Abi-Aad, A Belldegrun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapyT Cangiano, J Liao, J Naitoh, et al.
Seminars in Oncology|October 1, 1991
Renal cell carcinoma: basic biology and current approaches to therapyA Belldegrun, A S Abi-Aad, R A Figlin, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1991
Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injectionA S Abi-Aad, R A Figlin, A Belldegrun, et al.
European Urology|January 1, 1990
Immunotherapy for advanced renal cell cancer: the role of radical nephrectomyA Belldegrun, A S Koo, B Bochner, et al.
Urology|April 11, 2001
New biologicals for prostate cancer prevention: Genes, vaccines, and immune-based interventionsA J Pantuck, A Zisman, D Henderson, et al.
Cancer Journal (Sudbury, Mass.)|April 28, 2001
Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patientsB J Gitlitz, D M Hoffman, N Moldawer, et al.
European Journal of Radiology|May 1, 1986
CT diagnosis of adrenal abnormalities in patients with primary non-adrenal malignanciesS Hussain, A Belldegrun, S E Seltzer, et al.
Pageof 13